Biocompatibility of a novel avidin-agarose adsorbent for extracorporeal removal of redundant radiopharmaceutical from the blood

Artificial Organs

Volumn 31, Issue 3, 2007, Pages 208-214

  Kurkus, Jan ^a   Nilsson, Rune ^b   Lindén, Ola ^a   Schönström, Niki ^b   Sandberg, Bengt E B ^b   Tennvall, Jan ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b Mitra Medical AB   (Sweden)

Author keywords

Avidin agarose; Biocompatibility; Hemoadsorption; Radionuclide; Tumor specific antibodies

Indexed keywords

BIOCOMPATIBILITY; BLOOD; CELLS; CYTOLOGY; DRUG INTERACTIONS; GLYCOPROTEINS; MONOCLONAL ANTIBODIES; PATIENT TREATMENT; RADIOISOTOPES; TOXICITY; TUMORS;

ADSORBERS; AFFINITY ADSORPTION; AGAROSE; AVIDIN-AGARISE; CELL/B.E; CYTOTOXIC; HEMOADSORPTION; TUMOR-SPECIFIC ANTIBODY; TUMOR-TARGETING; TUMOUR CELLS;

BINDING ENERGY;

ACID CITRATE DEXTROSE; ADSORBENT; AGAROSE; ANTIBODY CONJUGATE; AVIDIN; BRADYKININ; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C5A; HEMOGLOBIN BETA CHAIN; HEPARIN; INDIUM 111; MONOCLONAL ANTIBODY; RADIOPHARMACEUTICAL AGENT; RITUXIMAB; SODIUM CHLORIDE; YTTRIUM 90;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; BIOCOMPATIBILITY; BIOTINYLATION; BLOOD CELL; BLOOD COMPONENT; CANCER IMMUNOTHERAPY; CLINICAL ARTICLE; DRUG BINDING; DRUG ISOLATION; DRUG LABELING; DRUG TARGETING; EXTRACORPOREAL AFFINITY ADSORPTION TREATMENT; FEMALE; HEMADSORPTION; HEMODILUTION; HUMAN; IMMUNE STATUS; ISOTOPE LABELING; MALE; PRIORITY JOURNAL; THROMBOCYTE; TREATMENT FAILURE; TUMOR CELL;

EID: 33847690820     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/j.1525-1594.2007.00366.x     Document Type: Article

References (19)

1. DeNardo GL, Maddock SW, Sgouros G, Scheibe PO, DeNardo SJ. Immunoadsorption: an enhancement strategy for radioimmunotherapy. J Nucl Med 1993;34:1020-7.
2. Lindén O, Kurkus J, Garkavij M, et al. A novel platform for radioimmunotherapy: extracorporeal depletion of biotinylated and (90)Y-labeled rituximab in patients with refractory B-cell lymphoma. Cancer Biother Radiopharm 2005;20:457-66.
3. Garkavij M, Tennvall J, Strand SE, et al. Extracorporeal whole-blood immunoadsorption enhances radioimmunotargeting of iodine-125-labeled BR96-biotin monoclonal antibody. J Nucl Med 1997;38:895-901.
4. Hakim RM. Clinical implications of hemodialysis membrane biocompatibility. Kidney Int 1993;44:484-94.
5. Gurland HJ, Davison AM, Bonomini V, et al. Definition and terminology in biocompatibility. Nephrol Dial Transpl 1994;9:4-10.
6. Daugirdas JT, Ing TS. First use reactions during hemodialysis. A definition of subtypes. Kidney Int 1988;33:S-37-43.
7. Bosch T, Lennertz A, Duhr C, Fink E, Samtleben W. Ex vivo biocompatibility of avidin-agarose: a new device for direct adsorption of biotinylated antibodies from human whole blood. Artif Organs 2000;24:696-704.
8. Wang Z, Mårtensson L, Nilsson R, et al. Blood pharmacokinetics of various monoclonal antibodies labeled with a new trifunctional chelating reagent for simultaneous conjugation with 1,4,7,10-tetraazacyclododecane-N,N′, N″,N‴-tetraacetic acid and biotin before radiolabeling. Clin Cancer Res 2005;11:7171-7.
9. Wilbur DS, Chyan MK, Hamlin DK, et al. Trifunctional conjugation reagents. Reagents that contain a biotin and a radiometal chelation moiety for application to extracorporeal affinity adsorption of radiolabeled antibodies. Bioconjug Chem 2002;13:1079-92.
10. Nadler SB, Hidalgo JU, Bloch T. Prediction of blood volume in normal human adults. Surgery 1962;51:224-32.
11. Kahn R, Herwald H, Muller-Esterl W, et al. Contact-system activation in children with vasculitis. Lancet 2002;360:535-41.
12. Ward RA. Effects of haemodialysis on coagulation and platelets: are we measuring membrane biocompatibility? Nephrol Dial Transpl 1995;10:12-7.
13. Hakin RM, Breillatt J, Lazarus JM, Port FK Complement activation and hypersensitivity reactions to dialysis membranes. N Engl J Med 1984;311:878-82.
14. Dameche L, Brunet P, George F, et al. Meltspun cellulose diacetate and polysulfone membranes have the same effect on complement activation and expression of leukocyte adhesion molecules and complement receptors. Nephrol Dial Transpl 1995;10:33-8.
15. Schaefer RM, Hörl WH, Kokot K, Heidland A. Enhanced biocompatibility with a new cellulosic membrane: cuprophan versus Hemophan. Blood Purif 1987;5:262-7.
16. Schulman G, Hakim R, Arias R, Silverberg M, Kaplan AP, Arbeit L. Bradykinin generation by dialysis membranes: possible role in anaphylactic reaction. JASN 1993;3:1563-9.
17. Samuel A, Paganelli G, Chiesa R, et al. Detection of prosthetic vascular graft infection using avidin/indium-111-biotin scintigraphy. J Nucl Med 1996;37:55-61.
18. Cheung AK, Chenoweth DE, Otsuka D, Henderson LW. Compartmental distribution of complement activation products in artificial kidneys. Kidney Int 1986;30:74-80.
19. Schindler R, Beck W, Deppisch R, et al. Short bacterial DNA fragments: detection in dialysate and induction of cytokines. JASN 2004;15:3207-14.